CorMedix, Inc. (CRMD)
7.26
+0.19
(+2.69%)
USD |
NASDAQ |
Feb 25, 15:41
CorMedix Research and Development Expense (Quarterly) : 5.098M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 3.206B |
| Amicus Therapeutics, Inc. | 23.74M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Castle Biosciences, Inc. | 12.87M |